CHEST Members

Membership & Community

As a CHEST member, you’re part of a strong network of clinicians representing every profession and experience level in chest medicine. With us, you can develop personal and professional connections, cultivate your leadership skills, advocate for policies that improve access to health, and advance your career.

JOIN TODAY ABOUT MEMBERSHIP »

Advertisement


See what's happening

CHEST After Hours speakers

Present your story at CHEST After Hours

Only five storytellers will be selected to share a piece of their personal story as a clinician in chest medicine at CHEST After Hours, Monday, October 20, in Chicago. Submissions are due Thursday, August 7.

LEARN MORE »


Bridging Specialties®: Timely Diagnosis for NTM Pulmonary Disease and Bronchiectasis displayed on a laptop screen

Bridging Specialties program tackles NTM pulmonary disease and bronchiectasis

CHEST recently launched Bridging Specialties®: Timely Diagnosis for Nontuberculous Mycobacterial (NTM) Pulmonary Disease and Bronchiectasis as a way for primary care physicians and pulmonologists to collaborate and provide earlier and accurate diagnoses.

READ MORE »


A person in a white lab coat breaks a cigarette

CHEST joins tobacco and human rights initiative led by ASH

CHEST recently cosigned a letter from the Action on Smoking & Health (ASH) to the Human Rights Council that focused on public health as it relates to global morbidity and mortality caused by tobacco.

READ MORE »

Conversation starters: Topics you want to discuss

A man in scrubs holds medical equipment

In our navigational bronchoscopy ERA

In a new CHEST Physician® article, members of the Interventional Procedures Section discuss the importance of the VERITAS trial, which represents a turning point for interventional pulmonology, ushering in an era of high-quality comparative effectiveness trials poised to transform our approach to technology evaluation, implementation, and, ultimately, patient care.

READ MORE »


CT scan image

Update on the evaluation and management of interstitial lung abnormalities

New guidelines from the American Thoracic Society outline the screening and follow-up procedures for interstitial lung abnormalities (ILAs). In a CHEST Physician® article, members of the Interstitial Lung Disease Section highlight updates to the Fleischner Society ILA definition and recommendations outlined in the new guideline.

READ MORE »


Injection pen

The emerging role of biologic therapy in asthma-COPD overlap

Biologics such as dupilumab, mepolizumab, benralizumab, and tezepelumab are an emerging option for select patients with asthma-COPD overlap (ACO), particularly those with T2-high inflammatory phenotypes. In a CHEST Physician® article, members of the Asthma and COPD Section highlight biomarker studies that have shown a reduction in exacerbations for patients with ACO.

READ MORE »

Twitter icon

Join the conversation on social media and connect with members of the CHEST community.

Facebook icon Twitter icon Linked in icon YouTube icon Instagram icon

Advance your career. Become an FCCP.

When you become an FCCP (Fellow of the American College of Chest Physicians), you play an active role in advancing the field of chest medicine while enjoying the prestige of being associated with a distinctive group of chest medicine professionals.


“I have found being an FCCP to be rewarding on a personal level, as well as a professional level. It has provided me with connections to colleagues nationally and internationally, and it has opened the door to leadership opportunities.”

– Thomas Van der Kloot, MD, FCCP


FIND OUT MORE